Immunotherapy using BCG during remission induction and as the sole form of maintenance in acute myeloid leukaemia.

por Summerfield, G. P., Gibbs, T. J., Bellingham, A. J.
Publicado 1979

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk

por Sava, G P, Speedy, H E, Di Bernardo, M C, Dyer, M J S, Holroyd, A, Sunter, N J, Marr, H, Mansouri, L, Deaglio, S, Karabon, L, Frydecka, I, Jamroziak, K, Woszczyk, D, Juliusson, G, Smedby, K E, Jayne, S, Majid, A, Wang, Y, Dearden, C, Hall, A G, Mainou-Fowler, T, Jackson, G H, Summerfield, G, Harris, R J, Pettitt, A R, Allsup, D J, Bailey, J R, Pratt, G, Pepper, C, Fegan, C, Rosenquist, R, Catovsky, D, Allan, J M, Houlston, R S
Publicado 2015